Cargando…
Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane
TP53 is the most frequently mutated gene in cancers. Mutations lead to loss of p53 expression or expression of a mutant protein. Mutant p53 proteins commonly lose wild-type function, but can also acquire novel functions in promoting metastasis and chemoresistance. Previously, we uncovered a role for...
Autores principales: | Phatak, Vinaya, von Grabowiecki, Yannick, Janus, Justyna, Officer, Leah, Behan, Caron, Aschauer, Lydia, Pinon, Lucia, Mackay, Hannah, Zanivan, Sara, Norman, Jim C., Kelly, Michael, Le Quesne, John, Muller, Patricia A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904762/ https://www.ncbi.nlm.nih.gov/pubmed/33627632 http://dx.doi.org/10.1038/s41419-021-03497-y |
Ejemplares similares
-
Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Cancer
por: von Grabowiecki, Yannick, et al.
Publicado: (2021) -
R.C.P. 264
Publicado: (1987) -
R.C.P. 264 Meeting
Publicado: (1989) -
R.C.P. 264 : Problèmes Inverses
Publicado: (1986) -
R.C.P. 759 : Excitations Non-linéaires
Publicado: (1987)